abiraterone,olaparib
astrazeneca,merck
['propel', 'gu ', '$mrk', 'merck', 'astrazeneca', '$azn']
astrazeneca $azn and merck $mrk present final results of key secondary overall survival endpoint from phase iii propel trial at asco gu cancers symposium mos 42.1 vs 34.7mo
os hr 0.81 - 95%ci 0.67-1.00; p=0.0544 #sadthrombone 
Biotellytics / https://t.co/37itIfRolp = business intel service on listed European Bios / Views=mine only, RT-like=/=endorse, no advice. 16y in Tech (chip design)